Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1998 1
2004 2
2005 1
2006 1
2014 1
2015 4
2019 1
2021 1
2022 4
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
Thatcher N, Hirsch FR, Luft AV, Szczesna A, Ciuleanu TE, Dediu M, Ramlau R, Galiulin RK, Bálint B, Losonczy G, Kazarnowicz A, Park K, Schumann C, Reck M, Depenbrock H, Nanda S, Kruljac-Letunic A, Kurek R, Paz-Ares L, Socinski MA; SQUIRE Investigators. Thatcher N, et al. Lancet Oncol. 2015 Jul;16(7):763-74. doi: 10.1016/S1470-2045(15)00021-2. Epub 2015 Jun 1. Lancet Oncol. 2015. PMID: 26045340 Free article. Clinical Trial.
[Recommendations for quality standards in bronchoscopy].
Häussinger K, Ballin A, Becker HD, Bölcskei P, Dierkesmann R, Dittrich I, Frank W, Freitag L, Gottschall R, Guschall WR, Hartmann W, Hauck R, Herth F, Kirsten D, Kohlhäufl M, Kreuzer A, Loddenkemper R, Macha N, Markus A, Stanzel F, Steffen H, Wagner M; Working party on Recommendations for Quality Stanards in Endoscopy of the German Society of Pulmonology (Section Endoscopy). Häussinger K, et al. Among authors: dittrich i. Pneumologie. 2004 May;58(5):344-56. doi: 10.1055/s-2004-818406. Pneumologie. 2004. PMID: 15162262 German. No abstract available.
Nintedanib plus docetaxel after progression on first-line immunochemotherapy in patients with lung adenocarcinoma: Cohort C of the non-interventional study, VARGADO.
Grohé C, Wehler T, Dechow T, Henschke S, Schuette W, Dittrich I, Hammerschmidt S, Müller-Huesmann H, Schumann C, Krüger S, Atz J, Kaiser R. Grohé C, et al. Among authors: dittrich i. Transl Lung Cancer Res. 2022 Oct;11(10):2010-2021. doi: 10.21037/tlcr-21-1018. Transl Lung Cancer Res. 2022. PMID: 36386456 Free PMC article.
Phase III study of second-line chemotherapy for advanced non-small-cell lung cancer with weekly compared with 3-weekly docetaxel.
Schuette W, Nagel S, Blankenburg T, Lautenschlaeger C, Hans K, Schmidt EW, Dittrich I, Schweisfurth H, von Weikersthal LF, Raghavachar A, Reissig A, Serke M. Schuette W, et al. Among authors: dittrich i. J Clin Oncol. 2005 Nov 20;23(33):8389-95. doi: 10.1200/JCO.2005.02.3739. J Clin Oncol. 2005. PMID: 16293869 Clinical Trial.
17 results